SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-158972
Filing Date
2024-06-11
Accepted
2024-06-11 13:54:55
Documents
9
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 6-K d845693d6k.htm 6-K 10957
2 EX-99.1 d845693dex991.htm EX-99.1 31977
3 EX-99.2 d845693dex992.htm EX-99.2 32685
4 EX-99.3 d845693dex993.htm EX-99.3 15429
5 EX-99.4 d845693dex994.htm EX-99.4 34668
6 GRAPHIC g845693g0527225640753.jpg GRAPHIC 2601
7 GRAPHIC g845693g06x08.gif GRAPHIC 1049
8 GRAPHIC g845693sp4.jpg GRAPHIC 7689
9 GRAPHIC g845693sp4g04.jpg GRAPHIC 4956
  Complete submission text file 0001193125-24-158972.txt   149604
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 241035342
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)